Jinfeng Qu

843 total citations
45 papers, 491 citations indexed

About

Jinfeng Qu is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jinfeng Qu has authored 45 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Ophthalmology, 15 papers in Molecular Biology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jinfeng Qu's work include Retinal Diseases and Treatments (17 papers), Glaucoma and retinal disorders (11 papers) and Retinal Imaging and Analysis (9 papers). Jinfeng Qu is often cited by papers focused on Retinal Diseases and Treatments (17 papers), Glaucoma and retinal disorders (11 papers) and Retinal Imaging and Analysis (9 papers). Jinfeng Qu collaborates with scholars based in China, United States and Iran. Jinfeng Qu's co-authors include Ilyas Washington, Haiquan Yang, Wei Shen, Wei Zou, Mingwei Zhao, Lanyu Li, Min Hou, Cheng Qiu, Xiaoxin Li and Mingwei Zhao and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Jinfeng Qu

41 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinfeng Qu China 13 220 180 141 76 60 45 491
Youn‐Shen Bee Taiwan 13 149 0.7× 158 0.9× 65 0.5× 21 0.3× 20 0.3× 33 427
Virginia Pearce United States 8 246 1.1× 69 0.4× 130 0.9× 49 0.6× 19 0.3× 9 557
Martina Cristaldi Italy 11 166 0.8× 55 0.3× 60 0.4× 60 0.8× 19 0.3× 20 358
Jianping Tong China 12 212 1.0× 333 1.9× 283 2.0× 27 0.4× 31 0.5× 53 632
Mahbubul H. Shihan United States 10 250 1.1× 160 0.9× 74 0.5× 21 0.3× 26 0.4× 18 541
Ming Jin China 13 328 1.5× 47 0.3× 46 0.3× 50 0.7× 16 0.3× 35 664
Jingxiang Zhong China 12 153 0.7× 72 0.4× 76 0.5× 45 0.6× 23 0.4× 23 385
Byung Joo Lee South Korea 12 185 0.8× 187 1.0× 112 0.8× 14 0.2× 11 0.2× 38 475
Mei Yan China 11 317 1.4× 61 0.3× 25 0.2× 166 2.2× 33 0.6× 31 585
Cristhian J. Ildefonso United States 14 361 1.6× 311 1.7× 77 0.5× 32 0.4× 14 0.2× 35 603

Countries citing papers authored by Jinfeng Qu

Since Specialization
Citations

This map shows the geographic impact of Jinfeng Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinfeng Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinfeng Qu more than expected).

Fields of papers citing papers by Jinfeng Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinfeng Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinfeng Qu. The network helps show where Jinfeng Qu may publish in the future.

Co-authorship network of co-authors of Jinfeng Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinfeng Qu. A scholar is included among the top collaborators of Jinfeng Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinfeng Qu. Jinfeng Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Li, Yuling, et al.. (2024). Role of microRNA-4739 in enhancing cisplatin chemosensitivity by negative regulation of RHBDD2 in human cervical cancer cells. Cellular & Molecular Biology Letters. 29(1). 20–20. 4 indexed citations
4.
Qu, Jinfeng, et al.. (2024). Identification of potential inhibitors against Staphylococcus aureus shikimate dehydrogenase through virtual screening and susceptibility test. Journal of Enzyme Inhibition and Medicinal Chemistry. 39(1). 2301768–2301768. 6 indexed citations
5.
Qu, Jinfeng, Xiuju Chen, Qinghuai Liu, et al.. (2023). Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial. Frontiers in Public Health. 10. 1067670–1067670. 3 indexed citations
6.
Zhang, Linqi, et al.. (2023). Optical coherence tomography angiography–guided vs indocyanine green angiography–guided half-dose photodynamic therapy for acute central serous chorioretinopathy: 6-month randomized trial results. Graefe s Archive for Clinical and Experimental Ophthalmology. 261(11). 3149–3158. 4 indexed citations
7.
Yan, Hui‐chao, et al.. (2023). Vitrectomy with sulfur hexafluoride versus air tamponade for idiopathic macular hole: a retrospective study. BMC Ophthalmology. 23(1). 331–331. 2 indexed citations
8.
Wang, Zongyi, et al.. (2023). Elevated number and density of macrophage-like cell as a novel inflammation biomarker in diabetic macular edema. Scientific Reports. 13(1). 12–16. 7 indexed citations
9.
Zeng, Qiaozhu, et al.. (2022). Comparison of 24×20 mm2 swept-source OCTA and fluorescein angiography for the evaluation of lesions in diabetic retinopathy. International Journal of Ophthalmology. 15(11). 1798–1805. 14 indexed citations
10.
Liu, Wenbo, Miao Zhou, Long Zhao, et al.. (2022). Diurnal changes of retinal microvascular circulation and RNFL thickness measured by optical coherence tomography angiography in patients with obstructive sleep apnea–hypopnea. Frontiers in Endocrinology. 13. 947586–947586. 3 indexed citations
11.
Zeng, Qiaozhu, et al.. (2022). Comparison of swept-source OCTA and indocyanine green angiography in central serous chorioretinopathy. BMC Ophthalmology. 22(1). 380–380. 7 indexed citations
12.
Qu, Jinfeng, et al.. (2022). A novel mutation of CYP4V2 gene associated with Bietti crystalline dystrophy complicated by choroidal neovascularization. International Journal of Ophthalmology. 15(6). 940–946. 4 indexed citations
13.
Qu, Jinfeng, Lvzhen Huang, Jie Hu, et al.. (2020). Comparison of the outcomes of photodynamic therapy for central serous chorioretinopathy with or without subfoveal fibrin. Eye. 35(2). 418–424. 9 indexed citations
14.
Hu, Jie, et al.. (2020). OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY-GUIDED PHOTODYNAMIC THERAPY FOR ACUTE CENTRAL SEROUS CHORIORETINOPATHY. Retina. 41(1). 189–198. 10 indexed citations
15.
Hu, Jie, et al.. (2019). Optical Coherence Tomography Angiography Compared with Indocyanine Green Angiography in Central Serous Chorioretinopathy. Scientific Reports. 9(1). 6149–6149. 17 indexed citations
16.
Cheng, Yong, Jinfeng Qu, Yi Chen, Mingwei Zhao, & Xiaoxin Li. (2015). Anterior Segment Neovascularization in Diabetic Retinopathy: A Masquerade. PLoS ONE. 10(6). e0123627–e0123627. 7 indexed citations
17.
Qu, Jinfeng, Li Ma, & Ilyas Washington. (2011). Retinal coenzyme Q in the bovine eye. BioFactors. 37(5). 393–398. 8 indexed citations
18.
Qu, Jinfeng, Mingwei Zhao, Yanrong Jiang, & Xiaoxin Li. (2011). VITRECTOMY OUTCOMES IN EYES WITH HIGH MYOPIC MACULAR HOLE WITHOUT RETINAL DETACHMENT. Retina. 32(2). 275–280. 17 indexed citations
19.
Qu, Jinfeng, Xiaoxin Li, & Bing-Ren Huang. (2005). Production of Recombinant Human Microplasminogen and Pilot Study in Inducing Posterior Vitreous Detachment. Current Eye Research. 30(10). 881–889. 4 indexed citations
20.
Qu, Jinfeng, et al.. (2003). A GIS-based prediction and assessment system of off-site accident consequence for Guangdong nuclear power plant. Radiation Protection Dosimetry. 106(3). 257–262. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youn‐Shen Bee Breakdown of academic impact, for papers by Virginia Pearce Breakdown of academic impact, for papers by Martina Cristaldi Breakdown of academic impact, for papers by Jianping Tong Breakdown of academic impact, for papers by Mahbubul H. Shihan Breakdown of academic impact, for papers by Ming Jin Breakdown of academic impact, for papers by Jingxiang Zhong Breakdown of academic impact, for papers by Byung Joo Lee Breakdown of academic impact, for papers by Mei Yan Breakdown of academic impact, for papers by Cristhian J. Ildefonso
Rankless by CCL
2026